Diffuse Bio develops generative AI models powered by biological data to accelerate protein design workflows. The platform allows researchers to design novel protein binders digitally, significantly reducing the time required compared to traditional laboratory methods. This technology provides a faster and more accurate approach for engineering new protein therapeutics.
Funding
$500K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional drug design methods often struggle to create novel proteins with specific functions and desired properties, limiting the development of effective treatments for diseases like flu, cancer, and COVID-19. Existing approaches can be slow, costly, and may not always yield proteins with the necessary characteristics for therapeutic applications.
Solution
Diffuse is developing a generative AI platform that enables the engineering of novel proteins with unprecedented control and accuracy. By leveraging AI-generated sequences and diffusion models, the platform facilitates the design of proteins tailored for specific therapeutic purposes. This technology allows for the creation of proteins with enhanced binding affinity, stability, and other desirable traits, accelerating the drug discovery process and expanding the possibilities for treating a wide range of diseases. The platform uses data-driven modeling of protein structure and sequence to produce full-atom backbone configurations as well as sequence and side-chain predictions.
Target Audience
The primary target audience includes pharmaceutical companies, biotechnology firms, and research institutions involved in drug discovery and protein engineering.
Features
- Generative AI models for de novo protein sequence and structure design
- Diffusion-based algorithms to generate novel protein sequences with desired properties
- AI-driven optimization of protein characteristics such as binding affinity and stability
- Data-driven modeling of protein structure and sequence
- Prediction of full-atom backbone configurations, sequences, and side-chains